2021
DOI: 10.1016/j.iac.2021.01.003
|View full text |Cite
|
Sign up to set email alerts
|

Food Allergies

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3

Citation Types

0
2
0

Year Published

2022
2022
2023
2023

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(3 citation statements)
references
References 103 publications
0
2
0
Order By: Relevance
“…[1][2][3] In the light of a notably increasing disease prevalence, OFC become an ever increasing burden for clinical centres where these challenge tests are performed. 4,5 There is a clear need for ex-vivo biomarkers that are predictive of clinical reactivity in order to reduce necessary OFC. [5][6][7] Clinical presentations, such as threshold reactivity, vary widely, which is part of the unpredictable nature of PA. [8][9][10] Several advances have already led to the discovery of diagnostic biomarkers associated with clinical outcome in PA.…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…[1][2][3] In the light of a notably increasing disease prevalence, OFC become an ever increasing burden for clinical centres where these challenge tests are performed. 4,5 There is a clear need for ex-vivo biomarkers that are predictive of clinical reactivity in order to reduce necessary OFC. [5][6][7] Clinical presentations, such as threshold reactivity, vary widely, which is part of the unpredictable nature of PA. [8][9][10] Several advances have already led to the discovery of diagnostic biomarkers associated with clinical outcome in PA.…”
Section: Introductionmentioning
confidence: 99%
“…Diagnostic food challenges (oral food challenge [OFC]) are the gold standard to diagnose peanut allergy (PA) and to monitor the progression or the impact of therapeutic intervention, such as oral immunotherapy (OIT), on threshold dose reactivity 1–3 . In the light of a notably increasing disease prevalence, OFC become an ever increasing burden for clinical centres where these challenge tests are performed 4,5 . There is a clear need for ex‐vivo biomarkers that are predictive of clinical reactivity in order to reduce necessary OFC 5–7 …”
Section: Introductionmentioning
confidence: 99%
“…In the last 10 years, there has been an increase in allergic diseases, including food allergies. Food allergy affects more than 1% to 2% and less than 10% of the population, but it is still unclear whether the prevalence is increasing [1,4]. Changes in the population's lifestyle or new eating habits may be responsible for the increased prevalence of food allergies [5].…”
Section: Introductionmentioning
confidence: 99%